CD93 Ameliorates Diabetic Wounds by Promoting Angiogenesis via the p38MAPK/MK2/HSP27 Axis

Eur J Vasc Endovasc Surg. 2023 Nov;66(5):707-721. doi: 10.1016/j.ejvs.2023.06.001. Epub 2023 Jun 7.

Abstract

Objective: Diabetic wounds are a complication of diabetes mellitus, which is characterised by microcirculation dysfunction caused by decreased local blood supply and insufficient metabolic exchange. Clinically, in addition to glycaemic control, the most important treatment for diabetic wounds is to promote local angiogenesis, which accelerates wound healing. The authors previous study demonstrated that CD93, which is specifically expressed on vascular endothelial cells (ECs), redundantly regulates angiogenesis in zebrafish, suggesting that CD93 is a potential angiogenic molecule. However, the role of CD93 in diabetic wounds has not yet been elucidated.

Methods: The angiogenic effects of CD93 were studied from four aspects: exogenous, endogenous, in vitro, and in vivo. CD93 recombinant protein was used in microvascular ECs and in mice to observe angiogenesis in vitro and in vivo. The wound model was established in CD93-/- and wild type diabetic mice, and the degree of wound healing as well as the amount and maturity of neovascularisation were investigated. The possible mechanism of CD93 in angiogenesis was determined by CD93 overexpression in cultured ECs.

Results: CD93 recombinant protein was found to exogenously promote tube formation and sprouting of ECs. It also recruited cells to promote the formation of vascular like structures in subcutaneous tissue and accelerated wound healing by optimising angiogenesis and re-epithelisation. Furthermore, CD93 deficiency was observed to delay wound repair, characterised by reduced neovascularisation, vascular maturity, and re-epithelisation level. Mechanically, CD93 activated the p38MAPK/MK2/HSP27 signalling pathway, positively affecting the angiogenic functions of ECs.

Conclusion: This study demonstrated that CD93 promotes angiogenesis both in vitro and in vivo and that its angiogenic role in vitro is mediated by the p38MAPK/MK2/HSP27 signalling pathway. It was also found that CD93 exerts beneficial effects on wound healing in diabetic mice by promoting angiogenesis and re-epithelisation.

Keywords: Angiogenesis; CD93; Diabetic wound; Re-epithelisation; p38MAPK.

Publication types

  • Comment

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental* / complications
  • Endothelial Cells
  • HSP27 Heat-Shock Proteins* / genetics
  • HSP27 Heat-Shock Proteins* / pharmacology
  • Mice
  • Mitogen-Activated Protein Kinase 14
  • Neovascularization, Pathologic
  • Neovascularization, Physiologic
  • Recombinant Proteins / pharmacology
  • Zebrafish

Substances

  • HSP27 Heat-Shock Proteins
  • Recombinant Proteins
  • MAP-kinase-activated kinase 2
  • Hspb2 protein, mouse
  • complement 1q receptor
  • Mitogen-Activated Protein Kinase 14